FeNNix
About FeNNix
FeNNix
FeNNix-Bio1 is a quantum AI foundation model developed by Qubit Pharmaceuticals and Sorbonne University that transforms molecular simulations across biomolecular and pharmaceutical research. Trained entirely on synthetic quantum chemistry data, FeNNix-Bio1 integrates high-accuracy quantum methods including Density Functional Theory (DFT), Quantum Monte Carlo (QMC), and Configuration Interaction (CI) to build comprehensive generalizable representation of interatomic forces. Development enabled by exascale high-performance computing resources from GENCI, EuroHPC, and Argonne. Can be trained in few hours using standard GPU whereas other AI models require weeks of supercomputing time. Enables reactive molecular dynamics simulations at scale and accuracy previously unattainable, including formation and breaking of chemical bonds, proton transfer, and quantum nuclear effects. Applications extend beyond pharmaceuticals to industrial enzymes, desalination membranes, next-generation batteries, and green chemistry. Qubit Pharmaceuticals based in Paris and Boston with team over 60 people from 18+ nationalities.
Company Information
- Founded: 2020
- Country: France
- Website: https://www.qubit-pharmaceuticals.com
- Categories: quantum chemistry, quantum ai, quantum software
Related Companies
Explore other quantum computing companies in similar categories or regions.
Company Information
⚠️ Important Disclaimer
Information for Educational Purposes Only: All information about FeNNix is provided for informational and educational purposes only. This is not investment, financial, or professional advice.
No Warranties: While we strive for accuracy, Quantum Zeitgeist makes no warranties regarding the accuracy, completeness, or timeliness of company information. The quantum technology industry evolves rapidly, and information may become outdated.
No Endorsement: Inclusion in Quantum Navigator does not constitute an endorsement, recommendation, or verification of FeNNix's claims, technology, or business viability.
Do Your Own Research: Always conduct independent due diligence and consult qualified professionals (financial advisors, lawyers, etc.) before making investment, business, or career decisions.
For more information, see our Terms of Service and Privacy Policy.